NEWLINK GENETICS CORP's ticker is NLNK and the CUSIP is 651511107. A total of 128 filers reported holding NEWLINK GENETICS CORP in Q3 2017. The put-call ratio across all filers is 0.36 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $412,000 | – | 40,468 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 1,840,294 | $34,561,000 | 3.61% |
| RA Capital Management | 500,000 | $9,390,000 | 0.98% |
| Knoll Capital Management, LLC | 77,437 | $1,454,000 | 0.78% |
| WALL STREET ASSOCIATES | 349,800 | $6,569,000 | 0.61% |
| Montibus Capital Management LLC | 251,811 | $4,729,011,000 | 0.51% |
| PointState Capital LP | 1,000,000 | $18,780,000 | 0.32% |
| Prospera Financial Services Inc | 40,826 | $838,000 | 0.32% |
| TIVERTON ASSET MANAGEMENT LLC | 500,000 | $9,390,000 | 0.23% |
| BAILARD, INC. | 46,000 | $864,000 | 0.16% |
| BANKERS TRUST CO | 12,277 | $231,000 | 0.16% |